Endoscopic variceal ligation plus beta‐blockers (EVL+ BB) is currently recommended for
variceal rebleeding prophylaxis, a recommendation that extends to all patients with cirrhosis …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and associated
morbidity and mortality worldwide. Short-course, oral, curative, direct-acting antiviral …

Page 1 World Health Organization UPDATED RECOMMENDATIONS ON TREATMENT OF
ADOLESCENTS AND CHILDREN WITH CHRONIC HCV INFECTION, AND HCV SIMPLIFIED …

HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

The global tuberculosis (TB) and child health community has increasingly prioritized the
childhood TB epidemic. In 2013, the childhood TB subgroup developed and published the …

No all‐oral, direct‐acting antiviral regimens have been approved for children with chronic
hepatitis C virus (HCV) infection. We conducted a phase 2, multicenter, open‐label study to …

Cystic fibrosis (CF)‐associated liver disease (CFLD) is a hepatobiliary complication of CF.
Current diagnostic modalities rely on nonspecific assessments, whereas liver biopsy is the …

Liver biopsy (LB) is still the criterion standard procedure for obtaining liver tissue for
histopathological examination and a valuable tool in the diagnosis, prognosis, and …

Hepatitis C virus (HCV) is an RNA virus that affects> 180 million individuals worldwide with a
high propensity for chronic infection. Children with HCV infection differ from adults in several …

Objectives: In 2017, the European Medicines Agency and the Food and Drug Administration
approved the use of the fixed-dose combination of ledipasvir/sofosbuvir and of the …